{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:53:33Z","timestamp":1789656813460,"version":"4.0.1"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.brainresbull.2018.03.006","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T15:50:25Z","timestamp":1521388225000},"page":"292-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"C","title":["Involvement of GABAergic, BDNF and Nox-2 mechanisms in the prevention and reversal of ketamine-induced schizophrenia-like behavior by morin in mice"],"prefix":"10.1016","volume":"139","author":[{"given":"Benneth","family":"Ben-Azu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adegbuyi Oladele","family":"Aderibigbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6586-0421","authenticated-orcid":false,"given":"Abayomi Mayowa","family":"Ajayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya-Ebi Okubo","family":"Eneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Umukoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezekiel O.","family":"Iwalewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2018.03.006_bib0005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jep.2005.07.019","article-title":"Sedative, antiepileptic and antipsychotic effects o: Spondias mombin L. (Anacardiaceae) in mice and rats","volume":"103","author":"Ayoka","year":"2006","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0010","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fncel.2014.00254","article-title":"BDNF signaling and survival of striatal neurons","volume":"8","author":"Baydyuk","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neuropharm.2009.06.002","article-title":"Does schizophrenia arise from oxidative dysregulation of parvalbumininterneurons in the developing cortex?","volume":"57","author":"Behrens","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0020","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1126\/science.1148045","article-title":"Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase","volume":"318","author":"Behrens","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0025","doi-asserted-by":"crossref","first-page":"13957","DOI":"10.1523\/JNEUROSCI.4457-08.2008","article-title":"Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia","volume":"28","author":"Behrens","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0030","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1080\/13880209.2016.1190382","article-title":"Neuroprotective effects of the ethanol stem bark extracts of Terminalia ivorensis in ketamine-induced schizophrenia-like behaviours and oxidative damage in mice","volume":"54","author":"Ben-Azu","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0035","first-page":"1","article-title":"Morin pretreatment attenuates schizophrenia-like behaviors in experimental animal models","volume":"67","author":"Ben-Azu","year":"2017","journal-title":"Drug Res."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0040","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.brainresbull.2018.02.007","article-title":"Doxycycline prevents and reverses schizophrenic-like behaviors induced by ketamine in mice via modulation of oxidative, nitrergic and cholinergic pathways","volume":"139","author":"Ben-Azu","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.biopsych.2008.03.004","article-title":"N-Acetyl cysteine as a glutathione precursor for schizophrenia\u2014a double-blind randomized, placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0050","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0140-6736(77)91542-2","article-title":"Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses","volume":"2","author":"Bird","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1017\/S1461145702002894","article-title":"The GABAergic system in schizophrenia","volume":"5","author":"Blum","year":"2002","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0060","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/YCO.0b013e3283436eb7","article-title":"Brain-derived neurotrophic factor: findings in schizophrenia","volume":"24","author":"Buckley","year":"2011","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0065","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.bcp.2004.07.022","article-title":"The dietary flavonoids apigenin and (\u2212)-epigallocatechin gallate enhance the positive modulation by diazepam of the activation by GABA of recombinant GABAA receptors","volume":"68","author":"Campbell","year":"2004","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0070","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2174\/0929867323666160106150821","article-title":"Morin: a promising natural drug","volume":"23","author":"Caselli","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0075","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.neuropharm.2012.05.041","article-title":"Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in mice","volume":"63","author":"Chatterjee","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0080","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s11064-011-0670-4","article-title":"Evaluation of the antipsychotic potential of Panaxquinquefolium in ketamine induced experimentalpsychosis model in mice","volume":"37","author":"Chatterjee","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0085","doi-asserted-by":"crossref","first-page":"348","DOI":"10.21010\/ajtcam.v14i2.36","article-title":"Morin mitigates oxidative stress, apoptosis and inflammation in cerebral ischemic rats","volume":"14","author":"Chen","year":"2017","journal-title":"Afri. J. Tradit. Complement. Altern. Med."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0090","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.pnpbp.2012.04.018","article-title":"Ketamine enhanced immobility in forced swim test: a possible animal model for the negative symptoms of schizophrenia","volume":"38","author":"Chindo","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0095","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.fct.2005.12.002","article-title":"A 13-week subchronic toxicity study of dietary administered morin in F344 rats","volume":"44","author":"Cho","year":"2006","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0100","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3892\/ijo.2016.3546","article-title":"Combination treatment with flavonoid morin and telomerase inhibitor MST312 reduces cancer stem cell traits by targeting STAT3 and telomerase","volume":"49","author":"Chung","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nbd.2012.10.018","article-title":"Role of glutamic acid decarboxylase 67 in regulating corticalparvalbumin and GABA membrane transporter 1 expression: implications for schizophrenia","volume":"50","author":"Curley","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jpsychires.2016.09.017","article-title":"Reversal of schizophrenia-like symptoms and immune alterations in mice by immunomodulatory drugs","volume":"84","author":"da Silva","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0115","doi-asserted-by":"crossref","first-page":"41720","DOI":"10.1074\/jbc.M112.405415","article-title":"LIM kinase 1 (LIMK1) interacts with tropomyosin-related kinase B (TrkB) and mediates brain-derived neurotrophic factor (BDNF)-induced axonal elongation","volume":"287","author":"Dong","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0120","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.14440\/jbm.2014.36","article-title":"Advanced methods of microscope control using \u03bcManager software","volume":"1","author":"Edelstein","year":"2014","journal-title":"J. Biol. Methods"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s11920-008-0028-z","article-title":"Genetics of clinical features and subtypes of schizophrenia: a review of the recent literature","volume":"10","author":"Fanous","year":"2008","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0130","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/mp.2014.117","article-title":"Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications","volume":"20","author":"Fernandes","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0135","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1590\/1516-4446-2012-0858","article-title":"Ketamine alters behavior and decreases BDNF levels in the rat brain as a function of time after drug administration","volume":"35","author":"Fraga","year":"2013","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0140","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/npp.2015.117","article-title":"Glutamate decarboxylase 67 deficiency in a subset of GABAergic neurons induces schizophrenia-related phenotypes","volume":"40","author":"Fujihara","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0009-8981(91)90067-M","article-title":"A simple method for determination of serum catalase activity and revision of reference range","volume":"196","author":"Goth","year":"1991","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0150","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.nbd.2006.03.017","article-title":"Neuroprotection by two polyphenols following excitotoxicity and experimental ischemia","volume":"23","author":"Gottlieb","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0155","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0891-5849(94)90202-X","article-title":"The correlation between active oxygens scavenging and antioxidative effects of flavonoids","volume":"16","author":"Hanasaki","year":"1994","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0160","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archpsyc.59.6.521","article-title":"Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia","volume":"59","author":"Heckers","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0165","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000454985","article-title":"Nardostachys jatamansi targets BDNF TrkB toAlleviate ketamine-induced schizophrenia-likesymptoms in rats","volume":"74","author":"Janardhanan","year":"2016","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0170","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1113\/jphysiol.2014.279083","article-title":"5-Hydroxytryptamine1A receptor-activation hyperpolarizespyramidal cells and suppresses hippocampal gammaoscillations via Kir3 channel activation","volume":"592","author":"Johnston","year":"2014","journal-title":"J. Physiol."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0175","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/73888","article-title":"Synapsin as mediator of BDNF-enhance neurotransmitter release","volume":"3","author":"Jovanovic","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0180","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1021\/acs.jafc.6b05147","article-title":"Suppression of lipopolysaccharide-induced neuroinflammation by morin via MAPK, PI3\u202fK\/Akt, and PKA\/HO-1 signaling pathway modulation","volume":"65","author":"Jung","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0185","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1371\/journal.pone.0041663","article-title":"Protective role of morin a flavonoid, against high glucose induced oxidative stress mediated apoptosis in primary Rat hepatocytes","volume":"7","author":"Kapoor","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0190","doi-asserted-by":"crossref","first-page":"8537","DOI":"10.1021\/jf051985c","article-title":"Effects of naturally occurring compounds on fibril formation and oxidative stress of betaamyloid","volume":"53","author":"Kim","year":"2005","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0195","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.schres.2016.01.023","article-title":"Impaired hippocampal-dependent memory and reduced parvalbumin-positive interneurons in a ketamine mouse model of schizophrenia","volume":"171","author":"Koh","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0200","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1523\/JNEUROSCI.14-04-02435.1994","article-title":"Role of dynorphin and GABA in the inhibitory regulation of NMDA-induced dopamine release in striosome- and matrix-enriched areas of the rat striatum","volume":"14","author":"Krebs","year":"1995","journal-title":"J. Neurosci"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0205","doi-asserted-by":"crossref","first-page":"5990","DOI":"10.1021\/bi300113x","article-title":"Morin inhibits the early stages of amyloid \u03b2-peptide aggregation by altering tertiary and quaternary interactions to produce \u201coff-pathway\u201d structures","volume":"51","author":"Lemkul","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0210","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrn1648","article-title":"Cortical inhibitory neurons and schizophrenia","volume":"6","author":"Lewis","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0215","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1176\/appi.ajp.2008.08030395","article-title":"Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia","volume":"165","author":"Lewis","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0220","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.biopha.2016.10.001","article-title":"Anticancer effects of morin-7-sulphate sodium a flavonoid derivative, in mouse melanoma cells","volume":"84","author":"Li","year":"2016","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0225","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/j.1460-9568.1993.tb00213.x","article-title":"Brain-derived neurotrophic factor is a survival factor for cultured rat cerebellar granule neurons and protects them against glutamate-induced neurotoxicity","volume":"5","author":"Lindholm","year":"1993","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0230","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2174\/1568026023393462","article-title":"GABA-A receptor ligands of flavonoid structure","volume":"2","author":"Marder","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0235","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/jamapsychiatry.2015.0575","article-title":"Psychotic experience s in the general population a cross-national analysis based on 31261 respondents from 18 countries","volume":"72","author":"McGrath","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0240","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/S0021-9258(19)45228-9","article-title":"The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase","volume":"247","author":"Misra","year":"1972","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0245","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/dbio.1994.1250","article-title":"Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons","volume":"165","author":"Mizuno","year":"1994","journal-title":"Dev. Biol."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0250","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1819.2009.01945.x","article-title":"Cytokines and schizophrenia: microglia hypothesis of schizophrenia","volume":"63","author":"Monji","year":"2009","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0255","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pnpbp.2011.12.002","article-title":"Neuroinflammation in schizophrenia especially focused on the role of microglia","volume":"42","author":"Monji","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0260","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1177\/0269881113503506","article-title":"Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: possible involvement of antioxidant and nitrergic pathway","volume":"11","author":"Monte","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0265","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pharmthera.2010.07.004","article-title":"Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism","volume":"128","author":"Neill","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0270","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.rbp.2012.02.005","article-title":"Effects of pregabalin on behavioral alterationsinduced by ketamine in rats","volume":"4","author":"Nunes","year":"2012","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0275","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s10072-014-1628-5","article-title":"Flavonoid, morin inhibits oxidative stress, inflammation and enhances neurotrophic support in the brain of streptozotocin-induced diabetic rats","volume":"35","author":"Ola","year":"2014","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0280","article-title":"Morin hydrate mitigates rapid eye movement sleep deprivation-induced neurobehavioural impairments and loss of viable neurons in the hippocampus of mice","author":"Olonode","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0285","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0140-6736(79)90767-0","article-title":"Gamma-aminobutyric-acid deciency in brain of schizophrenic patients","volume":"1","author":"Perry","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0290","doi-asserted-by":"crossref","first-page":"8236","DOI":"10.1523\/JNEUROSCI.18-20-08236.1998","article-title":"Induction of NF-kappa B activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappa B and neuroprotection by antioxidants","volume":"18","author":"Post","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0295","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0891-5849(89)90041-5","article-title":"Peroxidation induced changes in synaptosomal transport of dopamine and gammaaminobutyric acid","volume":"6","author":"Rafalowska","year":"1989","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0300","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1523\/JNEUROSCI.20-01-00485.2000","article-title":"Destruction and creation of spatial tuning by disinhibition: GABAA blockade of prefrontal cortical neurons engaged by working memory","volume":"20","author":"Rao","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0305","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/sj.mp.4001642","article-title":"The neurodevelopmental model of schizophrenia: update 2005","volume":"10","author":"Rapoport","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0310","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2174\/13895575113136660100","article-title":"Haloperidol cytotoxicity and its relation to oxidative stress","volume":"13","author":"Raudenska","year":"2013","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0315","first-page":"468","article-title":"Prospects for research on schizophrenia. An hypotheses suggesting that there is a defect in the GABA system in schizophrenia","volume":"10","author":"Roberts","year":"1972","journal-title":"Neurosci. Res. Program Bull."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0320","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.nlm.2013.12.015","article-title":"Improving cognition in schizophrenia with antipsychotics that elicit neurogenesis through 5-HT1A receptor activation","volume":"110","author":"Schreiber","year":"2014","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0325","first-page":"153","article-title":"Morin attenuates haloperidol induced tardive dyskinesia and oxidative stress in mice","volume":"2","author":"Selvakumar","year":"2012","journal-title":"J. Nat. Sci. Res."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0330","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ddr.21377","article-title":"Morin inhibits proliferation, migration, and invasion of bladder cancer E J cells via modulation of signaling pathways, cell cycle regulators, and transcription factor-mediated MMP-9 expression","volume":"78","author":"Shin","year":"2017","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0335","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.breast.2010.11.003","article-title":"Tamoxifen: cytochrome P450 genes and breast cancer clinical outcomes","volume":"20","author":"Singh","year":"2010","journal-title":"Breast"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0340","doi-asserted-by":"crossref","first-page":"11317","DOI":"10.1523\/JNEUROSCI.1491-10.2010","article-title":"The NADPH oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine responses","volume":"30","author":"Sorce","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0345","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0928-0987(00)00178-0","article-title":"Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine","volume":"12","author":"Suzuki","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0350","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00702-009-0232-y","article-title":"Effect of alpha lipoic acid on the tardive dyskinesia and oxidative stress induced by haloperidol in rats","volume":"116","author":"Thaakur","year":"2009","journal-title":"J. Neural. Transm. (Vienna)"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0355","first-page":"44","article-title":"Changes in oxidative stress markers in patients with schizophrenia: the effect of antipsychotic drugs","volume":"13","author":"Tsai","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0360","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/wps.20310","article-title":"Psychosis as a transdiagnostic and extended phenotype in the general population","volume":"15","author":"van Os","year":"2016","journal-title":"World Psychiatry"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0365","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.etap.2013.11.017","article-title":"Modulatory effects of morin on hyperglycemia by attenuating the hepatic key enzymes of carbohydrate metabolism and \u00ce2-cell function in streptozotoc ininduced diabetic rats","volume":"37","author":"Vanitha","year":"2014","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0370","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2017.02.026","article-title":"Morin activates the Nrf2-ARE pathway and reduces oxidative stress-induced DNA damage in pancreatic beta cells","volume":"801","author":"Vanitha","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0375","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.schres.2015.04.017","article-title":"Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: participation of antioxidant, nitrergic and neurotrophic mechanisms","volume":"165","author":"Vasconcelos","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0380","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archpsyc.57.3.237","article-title":"Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia","volume":"57","author":"Volk","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0385","first-page":"345","article-title":"Benzodiazepines in combination with antipsychotic drugs for schizophrenia: GABA-ergic targeted therapy","volume":"29","author":"W\u0142odarczyk","year":"2017","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0390","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2174\/156800705774322030","article-title":"Neuroactive flavonoids interacting with GABAA receptor complex","volume":"4","author":"Wang","year":"2005","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0395","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1176\/ajp.148.6.714","article-title":"Benzodiazepines in the treatment of schizophrenia: a review and reappraisal","volume":"148","author":"Wolkowitz","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0400","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1471-4159.1999.0730041.x","article-title":"Brain derived neurotrophic factor stimulates interactions of Shp2 with phosphatidylinositol 3-kinase and Grb2 in cultured cerebral cortical neurons","volume":"73","author":"Yamada","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0405","first-page":"314","article-title":"Neuroleptic malignant syndrome in a head injury patient treated with haloperidol","volume":"18","author":"Yen","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0410","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1124\/jpet.105.092684","article-title":"The dual actions of morin (3, 5, 7, 2, 4-penta hydroxyl flavone) as a hypouricemic agent: uricosuric effect and xanthine oxidase inhibitory activity","volume":"316","author":"Yu","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0415","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/npp.2015.117","article-title":"Glutamate decarboxylase 67 deficiency in a subset of GABAergic neurons induces schizophrenia-related phenotypes","volume":"40","author":"Yuchio","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0420","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00004714-200102000-00015","article-title":"The effect of extract of Ginkgo biloba added to haloperidol on superoxide dismutase in inpatients with chronic schizophrenia","volume":"21","author":"Zhang","year":"2001","journal-title":"J. Clin Psychopharmacol."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0425","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11427-010-0013-8","article-title":"A meta-analysis of oxidative stress markers in schizophrenia","volume":"53","author":"Zhang","year":"2010","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0430","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jphp.12492","article-title":"Biodistribution, hypouricemic efficacy and therapeutic mechanism of morin phospholipid complex loaded self-nanoemulsifying drug delivery systems in an experimental hyperuricemic model in rats","volume":"68","author":"Zhang","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0435","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.fct.2017.07.002","article-title":"Molecular mechanism of anti-cancerous potential of Morin extracted from mulberry in Hela cells","volume":"112","author":"Zhang","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.brainresbull.2018.03.006_bib0440","doi-asserted-by":"crossref","first-page":"93966","DOI":"10.1371\/journal.pone.0093966","article-title":"Minocycline and risperidone prevent microglia activation and rescue behavioral deficits induced by neonatal intrahippocampal injection of lipopolysaccharide in rats","volume":"9","author":"Zhu","year":"2014","journal-title":"PLoS One"}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923018301333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923018301333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:31:33Z","timestamp":1759782693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923018301333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":88,"alternative-id":["S0361923018301333"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2018.03.006","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of GABAergic, BDNF and Nox-2 mechanisms in the prevention and reversal of ketamine-induced schizophrenia-like behavior by morin in mice","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2018.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}